Garden State Life Sciences Venture Fund L P - Net Worth and Insider Trading

Garden State Life Sciences Venture Fund L P Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Garden State Life Sciences Venture Fund L P owns 1 companies in total, including Amicus Therapeutics Inc (FOLD) .

Click here to see the complete history of Garden State Life Sciences Venture Fund L P’s form 4 insider trades.

Insider Ownership Summary of Garden State Life Sciences Venture Fund L P

Ticker	Comapny	Transaction Date	Type of Owner
FOLD	Amicus Therapeutics Inc	2007-05-30	10 percent owner

Garden State Life Sciences Venture Fund L P Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Garden State Life Sciences Venture Fund L P Ownership Network

Ownership Network List of Garden State Life Sciences Venture Fund L P

No Data

Ownership Network Relation of Garden State Life Sciences Venture Fund L P

Garden State Life Sciences Venture Fund L P Owned Company Details

What does Amicus Therapeutics Inc do?

Who are the key executives at Amicus Therapeutics Inc?

Garden State Life Sciences Venture Fund L P is the 10 percent owner of Amicus Therapeutics Inc. Other key executives at Amicus Therapeutics Inc include director & President and CEO Bradley L Campbell , director & Executive Chairman John F Crowley , and Chief People Officer David Michael Clark .

Amicus Therapeutics Inc (FOLD) Insider Trades Summary

Over the past 18 months, Garden State Life Sciences Venture Fund L P made no insider transaction in Amicus Therapeutics Inc (FOLD). Other recent insider transactions involving Amicus Therapeutics Inc (FOLD) include a net sale of 232,762 shares made by Bradley L Campbell , a net sale of 333,235 shares made by John F Crowley , and a net sale of 95,000 shares made by Ellen Rosenberg .

In summary, during the past 3 months, insiders sold 30,401 shares of Amicus Therapeutics Inc (FOLD) in total and bought 0 shares, with a net sale of 30,401 shares. During the past 18 months, 803,781 shares of Amicus Therapeutics Inc (FOLD) were sold and 0 shares were bought by its insiders, resulting in a net sale of 803,781 shares.

Amicus Therapeutics Inc (FOLD)'s detailed insider trading history can be found in Insider Trading Tracker table.

Amicus Therapeutics Inc Insider Transactions

No Available Data

Garden State Life Sciences Venture Fund L P Mailing Address

Above is the net worth, insider trading, and ownership report for Garden State Life Sciences Venture Fund L P. You might contact Garden State Life Sciences Venture Fund L P via mailing address: 101 West Main St, Suite 200, Moorestown Nj 08057.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.